期刊文献+

TGF-β_1/Smad4信号传导系统在视网膜母细胞瘤株Hxo-Rb44的表达

Expression of TGF-β_1 /Smad4 transduction pathway in retinoblastoma cell line Hxo-Rb44
下载PDF
导出
摘要 目的探讨TGFβ1/Smad4信号传导系统在视网膜母细胞瘤株HxoRb44的表达及意义。方法用免疫荧光法检测TGFβ1、TGFβ受体Ⅱ及Smad4在该细胞株中的表达和定位。以已知TGFβ1、TGFβ受体Ⅱ及Smad4表达均为阳性的WI38细胞作对照,分别用RTPCR法和Westernblot法检测TGFβ1、TGFβ受体Ⅱ及Smad4的mRNA和蛋白质在视网膜母细胞瘤细胞株HxoRb44中的表达,并比较两种细胞表达水平的差异。结果免疫荧光检测结果发现视网膜母细胞瘤细胞株HxoRb44的TGFβ1呈阳性表达,主要位于胞浆和胞膜;TGFβRⅡ及Smad4阴性。视网膜母细胞瘤细胞株HxoRb44的TGFβ1的表达在mRNA水平和蛋白水平均高于作对照的WI38细胞;TGFβ受体Ⅱ及Smad4在mRNA水平和蛋白水平均为阴性。结论视网膜母细胞瘤细胞株HxoRb44高表达TGFβ1;对TGFβ1增殖抑制作用反应的丧失与视网膜母细胞瘤的发病有关。 ObjectiveTo investigate the expressions of transforming growth factor-beta1(TGF-β_1),TGF-β receptor (TGF-β R)Ⅱand Smad4 in retinoblastoma (Rb) cell line Hxo-Rb44.MethodsImmunofluorescence was used to locate the expression of TGF-β_1,TGF-β RⅡand Smad4 in cultured Rb cell line Hxo-Rb44,and RT-PCR and Western blot were used to detect the transcription and expression of TGF-β_1,TGF-β RⅡand Smad4 and the results were compared with WI-38,which served as positive control for the expression of TGF-β_1,TGF-βRⅡand Smad4.ResultsTGF-β_1 was expressed in Rb cell line Hxo-Rb44 and was mainly located in cellular membrane.The expression of TGF-β_1 was higher than that matched WI-38 cell at both mRNA and protein level.Both mRNA and protein of TGF-β RⅡand Smad4 were not expressed in Hxo-Rb44.ConclusionOverexpression of TGF-β_1 and the loss of TGF-β RⅡand Smad4 in Rb cell line Hxo-Rb44 may contribute to the formation of Rb.
出处 《眼科研究》 CAS CSCD 北大核心 2005年第3期266-268,共3页 Chinese Ophthalmic Research
关键词 视网膜母细胞瘤 转化生长因子Β1 转化生长因子受体Ⅱ SMAD4 retinoblastoma transforming growth factor-beta1 transforming growth factor-beta receptor Ⅱ Smad4
  • 相关文献

参考文献9

  • 1李洪燕,陈晓光.转化生长因子β与肿瘤研究进展[J].国外医学(肿瘤学分册),2002,29(1):17-20. 被引量:17
  • 2Dunker N,Schuster N,Krieglistein K.TGF-beta modulates programmed cell death in the retina of the developing chick embryo[J].Development,2001,128 (11): 1933-1942
  • 3Ikuno Y,Kazlauskas A.TGFbeta1-dependent contraction of fibroblasts is mediated by the PDGFalpha receptor[J].Invest Ophthalmol Vis Sci,2002,43(1):41-46
  • 4Pasche B.Role of transforming growth factor beta in cancer[J].J Cell Physiol,2001,186(2):153-168
  • 5Kinchi A,Wang XF,Weinberg RA,et al.Absence of TGF-β receptors and growth inhibitory response in retinoblastoma cells[J].Science,1988,240(4849):196-198
  • 6Horie K,Yamashita H,Mogi A,et al.Lack of transforming growth factor-β type Ⅱreceptor expression in human retinoblastoma cells[J].J Cell Phys,1998,175 (3): 305-313
  • 7Osada H,Tatemastu Y,Masuda A,et al.Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type Ⅱ expression caused by histone deacetylation in lung cancer cell lines[J].Cancer Res,2001,61(22): 8331-8339
  • 8Platten M,Wild-Bode C,Wick W,et al.N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta release and reduces migration and invasiveness of human malignant glioma cells[J].Int J Cancer,2001,93(1): 53-61
  • 9Norgaard P,Damstrup L,Rygaard K,et al.Growth suppression by transforming growth factor β1 of human small-cell lung cancer cell lines is associated with expression of the type Ⅱ receptor[J].Br J Cancer,1994,69(5):802-808

二级参考文献23

  • 1Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor in human disease[J]. N Engl J Med, 2000, 342(18): 1350-1358.
  • 2Imamura T, et al. Smad6 inhibits signaling by the TGF-β superfamily[J]. Nature, 1997, 389 (6651): 622-626.
  • 3Nakao A, Takase M, Nishihara A, etal. Identifieation of Smad7, a TGF-β-inducible antagonist of TGF-β-signaling [J]. Nature, 1997, 389(6651): 631-635.
  • 4Yoo YD, Choi JY, Lee SJ, et al. TGF-beta-induced cell-cycle arrest through the p21 (WAF1/C1P1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells[J]. Int J Cancer, 1999, 83(4): 512-517.
  • 5Lavarone A , Massague J. Repression of CDK activitor edc25A and cell-cycle arrest by cytokine TGF-β cells in lacking CDK inhibitor p15[J]. Nature, 1997, 387(6631): 417-422.
  • 6Grady WM., Myeroff LL, Swinler S E, et al. Mutational inactivation of transforming growth factor TGF-β receptor type Ⅱ in microsatellite stable colon cancers[J]. Cancer Res, 1999, 59(2): 320-324.
  • 7Goggins M. , Shekher M, Turnacioglu K, et al. Genetic alterations of the transforming growth factor-(receptor genes in pancteafic and biliary adenocarcinomas[J]. Cancer Res, 1998, 58(23): 5329-5332.
  • 8Kang SH, Bang YJ, Im YH, et al. Transcriptional repression of the transforming growth factor type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer[J]. Oncogene, 1999, 18(51): 7280-7286.
  • 9Kleeff J, Ishiwata T, Maruyana H, et al. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer[J]. Oncogene, 1999, 18(39): 5363-5372.
  • 10Hu W , Wu W, Nash MA, et al. Anomalies of TGF-beta postreceptor signaling pathway in ovarian cancer cell line[J]. Anticancer Res, 2000, 20(2A): 729-733.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部